Biotech

All Articles

Kailera launches along with $400M set A, 4 Chinese excessive weight medications

.Kailera Rehabs has introduced right into the progressively packed obesity space along with a portfo...

Metsera associate with Amneal to secure down GLP-1 supply

.With very early phase 1 records today out in the wild, metabolic ailment attire Metsera is actually...

Rivus articles information to back up muscle-sparing weight problems medication claims

.Rivus Pharmaceuticals has actually unveiled the records behind its period 2 excessive weight gain i...

BMS spends $110M to develop T-cell treatment deal, helping Perfect acquire time to advance prioritized pipe

.Bristol Myers Squibb is actually paying Excellent Medication $110 thousand beforehand to establish ...

Generate increases one more $1B-plus Major Pharma partnership

.Novartis has tattooed a package potentially worth much more than $1 billion along with Flagship-fou...

Metsera GLP-1 records cut exposes 7.5% weight reduction at 36 times

.Just recently debuted Metsera is unfolding some stage 1 record for its own GLP-1 receptor agonist, ...

Flagship hopes biotechs flock to Mirai to increase hereditary meds

.Amid the hereditary medicines branches race, Front runner Pioneering is introducing a brand new com...

BioAge eyes $180M from IPO, private placement for weight problems tests

.BioAge Labs is checking out about $180 million in preliminary proceeds from an IPO and an exclusive...

Merck's LAG-3 combo falls short colon cancer cells phase 3 research study

.A try through Merck &amp Co. to uncover the microsatellite steady (MSS) metastatic intestines cance...

Spanish VC shuts $200M lifestyle sciences fund

.Spain-based Asabys Allies has actually shut a fund of 180 thousand europeans ($ 200 thousand), fund...